307 related articles for article (PubMed ID: 11676154)
1. [Treatment of steroid-resistant polymyositis and dermatomyositis].
Mimura T; Kanda H; Kubo K
Nihon Rinsho; 2001 Oct; 59(10):2062-70. PubMed ID: 11676154
[TBL] [Abstract][Full Text] [Related]
2. A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis.
Mira-Avendano IC; Parambil JG; Yadav R; Arrossi V; Xu M; Chapman JT; Culver DA
Respir Med; 2013 Jun; 107(6):890-6. PubMed ID: 23517887
[TBL] [Abstract][Full Text] [Related]
3. Successful combined therapy of cyclophosphamide and cyclosporine for acute exacerbated interstitial pneumonia associated with dermatomyositis.
Tanaka F; Origuchi T; Migita K; Tominaga M; Kawakami A; Kawabe Y; Eguchi K
Intern Med; 2000 May; 39(5):428-30. PubMed ID: 10830189
[TBL] [Abstract][Full Text] [Related]
4. Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis.
Yoshida T; Koga H; Saitoh F; Sakamoto M; Harada M; Yoshida H; Sakisaka S; Sata M
Intern Med; 1999 Sep; 38(9):733-8. PubMed ID: 10480306
[TBL] [Abstract][Full Text] [Related]
5. Effective Use of Calcineurin Inhibitor in Combination Therapy for Interstitial Lung Disease in Patients With Dermatomyositis and Polymyositis.
Shimojima Y; Ishii W; Matsuda M; Kishida D; Ikeda SI
J Clin Rheumatol; 2017 Mar; 23(2):87-93. PubMed ID: 28225510
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I
J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic advances in myositis.
Aggarwal R; Oddis CV
Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
[TBL] [Abstract][Full Text] [Related]
8. [Polymyositis: disease course and therapy with intravenously administered immunoglobulins].
Stoll T; Michel BA; Neidhart M; Wassmer P; Neidl K; Fehr K; Wagenhäuser FJ
Schweiz Med Wochenschr; 1992 Sep; 122(39):1458-65. PubMed ID: 1411405
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis.
Suzuki Y; Hayakawa H; Miwa S; Shirai M; Fujii M; Gemma H; Suda T; Chida K
Lung; 2009; 187(3):201-6. PubMed ID: 19387736
[TBL] [Abstract][Full Text] [Related]
10. [New therapeutic approaches for polymyositis and dermatomyositis].
Dankó K; Vincze M
Orv Hetil; 2011 Sep; 152(39):1552-9. PubMed ID: 21920841
[TBL] [Abstract][Full Text] [Related]
11. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis.
Yamasaki Y; Yamada H; Yamasaki M; Ohkubo M; Azuma K; Matsuoka S; Kurihara Y; Osada H; Satoh M; Ozaki S
Rheumatology (Oxford); 2007 Jan; 46(1):124-30. PubMed ID: 16754626
[TBL] [Abstract][Full Text] [Related]
12. [Immunosuppressive therapy for nephrotic syndrome and strategy for adverse side effects from that therapy].
Takeda Y; Tomino Y
Nihon Rinsho; 2004 Oct; 62(10):1875-9. PubMed ID: 15500133
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis.
Kurita T; Yasuda S; Amengual O; Atsumi T
Lupus; 2015 Jan; 24(1):3-9. PubMed ID: 25297551
[TBL] [Abstract][Full Text] [Related]
14. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment.
Schnabel A; Reuter M; Biederer J; Richter C; Gross WL
Semin Arthritis Rheum; 2003 Apr; 32(5):273-84. PubMed ID: 12701038
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil therapy for juvenile dermatomyositis with immune thrombocytopenic purpura.
Ogimi C; Honma N; Tanaka R; Oh-ishi T
Mod Rheumatol; 2012 Apr; 22(2):280-3. PubMed ID: 21710356
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?
Maeda K; Kimura R; Komuta K; Igarashi T
Scand J Rheumatol; 1997; 26(1):24-9. PubMed ID: 9057798
[TBL] [Abstract][Full Text] [Related]
17. [Successful combination chemotherapy with low-dose methotrexate and steroids for dermatomyositis complicated by interstitial pneumonitis].
Itoh T; Mitsuoka S; Uji M; Matsushita H
Nihon Kokyuki Gakkai Zasshi; 1999 Aug; 37(8):636-40. PubMed ID: 10496104
[TBL] [Abstract][Full Text] [Related]
18. Interstitial lung disease due to polymyositis or dermatomyositis: effect of a 6-month course of i.v. pulse cyclophosphamide.
Meyer O; Hayem G; Palazzo E; Crestani B; Debray MP; Ballard M
Clin Exp Rheumatol; 2005; 23(5):724. PubMed ID: 16173257
[No Abstract] [Full Text] [Related]
19. WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
Choy EH; Hoogendijk JE; Lecky B; Winer JB; Gordon P
Cochrane Database Syst Rev; 2009 Oct; (4):CD003643. PubMed ID: 19821312
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
Choy EH; Hoogendijk JE; Lecky B; Winer JB
Cochrane Database Syst Rev; 2005 Jul; (3):CD003643. PubMed ID: 16034905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
